Black Rock Inc. Mustang Bio, Inc. Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.35 - $0.72 $70,268 - $144,551	-200,766 Reduced 13.25%	1,314,720 $486,000
Q4 2022 Feb 13, 2023	SELL	$0.32 - $8.27 $228,646 - $5.91 Million	-714,521 Reduced 32.04%	1,515,486 $591,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $15,248 - $238,672	-33,149 Reduced 1.46%	2,230,007 $1.05 Million
Q2 2022 Aug 12, 2022	SELL	$0.58 - $1.13 $1.98 Million - $3.86 Million	-3,418,056 Reduced 60.16%	2,263,156 $1.32 Million
Q1 2022 May 12, 2022	SELL	$0.73 - $1.81 $53,548 - $132,770	-73,354 Reduced 1.27%	5,681,212 $5.74 Million
Q4 2021 Feb 10, 2022	BUY	$1.66 - $2.64 $1.22 Million - $1.95 Million	736,952 Added 14.69%	5,754,566 $9.55 Million
Q3 2021 Nov 09, 2021	BUY	$2.58 - $3.36 $205,904 - $268,154	79,808 Added 1.62%	5,017,614 $13.5 Million
Q2 2021 Aug 11, 2021	BUY	$2.7 - $3.81 $13.3 Million - $18.8 Million	4,937,806 New	4,937,806 $16.4 Million

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.